Therefore, we hypothesised that the KIT–PLCγ2–PKD2 pathway activates PLD1 and/or PLD2, and that aberrant PA production leads to the mutant receptor’s retention in the Golgi/TGN in GIST cells. The gene discussed is PLD1; the disease is gastrointestinal stromal tumor.